Cell therapy for tendon repair in horses: an experimental study.

1. Cho SW, Park HJ, Ryu JH, Kim SH, Kim YH, Choi CY, Lee MJ, Kim JS, Jang IS, Kim DI, Kim BS. Vascular patches tissue-engineered with autologous bone marrow-derived cells and decellularized tissue matrices.. Biomaterials 2005 May;26(14):1915-24.
   pubmed: 15576165doi: 10.1016/j.biomaterials.2004.06.018google scholar: lookup
2. Smith RK, Korda M, Blunn GW, Goodship AE. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment.. Equine Vet J 2003 Jan;35(1):99-102.
   pubmed: 12553472doi: 10.2746/042516403775467388google scholar: lookup
3. Sharma P, Maffulli N. Tendon injury and tendinopathy: healing and repair.. J Bone Joint Surg Am 2005 Jan;87(1):187-202.
   pubmed: 15634833doi: 10.2106/JBJS.D.01850google scholar: lookup
4. Smith RK, Webbon PM. Harnessing the stem cell for the treatment of tendon injuries: heralding a new dawn?. Br J Sports Med 2005 Sep;39(9):582-4.
   pubmed: 16118291doi: 10.1136/bjsm.2005.015834google scholar: lookup
5. Blatt A, Cotter G, Leitman M, Krakover R, Kaluski E, Milo-Cotter O, Resnick IB, Samuel S, Gozal D, Vered Z, Slavin S, Shapira MY. Intracoronary administration of autologous bone marrow mononuclear cells after induction of short ischemia is safe and may improve hibernation and ischemia in patients with ischemic cardiomyopathy.. Am Heart J 2005 Nov;150(5):986.
   pubmed: 16290982doi: 10.1016/j.ahj.2005.07.021google scholar: lookup

Citations

1. Quintero D, Perucca Orfei C, Kaplan LD, de Girolamo L, Best TM, Kouroupis D. The roles and therapeutic potentialof mesenchymal stem/stromal cells and their extracellular vesicles in tendinopathies. Front Bioeng Biotechnol 2023;11:1040762.
   doi: 10.3389/fbioe.2023.1040762pubmed: 36741745google scholar: lookup
2. Tsang AS, Dart AJ, Biasutti SA, Jeffcott LB, Smith MM, Little CB. Effects of tendon injury on uninjured regional tendons in the distal limb: An in-vivo study using an ovine tendinopathy model. PLoS One 2019;14(4):e0215830.
   doi: 10.1371/journal.pone.0215830pubmed: 31013317google scholar: lookup
3. Sultana T, Lee S, Yoon HY, Lee JI. Current Status of Canine Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Veterinary Medicine. Stem Cells Int 2018;2018:8329174.
   doi: 10.1155/2018/8329174pubmed: 30123294google scholar: lookup
4. Barboni B, Russo V, Berardinelli P, Mauro A, Valbonetti L, Sanyal H, Canciello A, Greco L, Muttini A, Gatta V, Stuppia L, Mattioli M. Placental Stem Cells from Domestic Animals: Translational Potential and Clinical Relevance. Cell Transplant 2018 Jan;27(1):93-116.
   doi: 10.1177/0963689717724797pubmed: 29562773google scholar: lookup
5. Berner D, Brehm W, Gerlach K, Gittel C, Offhaus J, Paebst F, Scharner D, Burk J. Longitudinal Cell Tracking and Simultaneous Monitoring of Tissue Regeneration after Cell Treatment of Natural Tendon Disease by Low-Field Magnetic Resonance Imaging. Stem Cells Int 2016;2016:1207190.
   doi: 10.1155/2016/1207190pubmed: 26880932google scholar: lookup
6. Sullivan MO, Gordon-Evans WJ, Fredericks LP, Kiefer K, Conzemius MG, Griffon DJ. Comparison of Mesenchymal Stem Cell Surface Markers from Bone Marrow Aspirates and Adipose Stromal Vascular Fraction Sites. Front Vet Sci 2015;2:82.
   doi: 10.3389/fvets.2015.00082pubmed: 26835460google scholar: lookup
7. Maia L, da Cruz Landim-Alvarenga F, Taffarel MO, de Moraes CN, Machado GF, Melo GD, Amorim RM. Feasibility and safety of intrathecal transplantation of autologous bone marrow mesenchymal stem cells in horses. BMC Vet Res 2015 Mar 15;11:63.
   doi: 10.1186/s12917-015-0361-5pubmed: 25879519google scholar: lookup
8. Docheva D, Müller SA, Majewski M, Evans CH. Biologics for tendon repair. Adv Drug Deliv Rev 2015 Apr;84:222-39.
   doi: 10.1016/j.addr.2014.11.015pubmed: 25446135google scholar: lookup
9. Schnabel LV, Pezzanite LM, Antczak DF, Felippe MJ, Fortier LA. Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro. Stem Cell Res Ther 2014 Jan 24;5(1):13.
   doi: 10.1186/scrt402pubmed: 24461709google scholar: lookup
10. Smith RK, Werling NJ, Dakin SG, Alam R, Goodship AE, Dudhia J. Beneficial effects of autologous bone marrow-derived mesenchymal stem cells in naturally occurring tendinopathy. PLoS One 2013;8(9):e75697.
    doi: 10.1371/journal.pone.0075697pubmed: 24086616google scholar: lookup
11. Carvalho Ade M, Badial PR, Álvarez LE, Yamada AL, Borges AS, Deffune E, Hussni CA, Garcia Alves AL. Equine tendonitis therapy using mesenchymal stem cells and platelet concentrates: a randomized controlled trial. Stem Cell Res Ther 2013 Jul 22;4(4):85.
    doi: 10.1186/scrt236pubmed: 23876512google scholar: lookup
12. Tetta C, Consiglio AL, Bruno S, Tetta E, Gatti E, Dobreva M, Cremonesi F, Camussi G. The role of microvesicles derived from mesenchymal stem cells in tissue regeneration; a dream for tendon repair?. Muscles Ligaments Tendons J 2012 Jul;2(3):212-21.
    pubmed: 23738299
13. Reed SA, Johnson SE. Expression of scleraxis and tenascin C in equine adipose and umbilical cord blood derived stem cells is dependent upon substrata and FGF supplementation. Cytotechnology 2014 Jan;66(1):27-35.
    doi: 10.1007/s10616-012-9533-3pubmed: 23299298google scholar: lookup
14. Spaas JH, Guest DJ, Van de Walle GR. Tendon regeneration in human and equine athletes: Ubi Sumus-Quo Vadimus (where are we and where are we going to)?. Sports Med 2012 Oct 1;42(10):871-90.
    doi: 10.1007/BF03262300pubmed: 22963225google scholar: lookup
15. Young M. Stem cell applications in tendon disorders: a clinical perspective. Stem Cells Int 2012;2012:637836.
    doi: 10.1155/2012/637836pubmed: 22448174google scholar: lookup
16. Shenaq DS, Rastegar F, Petkovic D, Zhang BQ, He BC, Chen L, Zuo GW, Luo Q, Shi Q, Wagner ER, Huang E, Gao Y, Gao JL, Kim SH, Yang K, Bi Y, Su Y, Zhu G, Luo J, Luo X, Qin J, Reid RR, Luu HH, Haydon RC, He TC. Mesenchymal Progenitor Cells and Their Orthopedic Applications: Forging a Path towards Clinical Trials. Stem Cells Int 2010 Dec 16;2010:519028.
    doi: 10.4061/2010/519028pubmed: 21234334google scholar: lookup
17. Koch TG, Berg LC, Betts DH. Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine. Can Vet J 2009 Feb;50(2):155-65.
    pubmed: 19412395
18. Koch TG, Berg LC, Betts DH. Concepts for the clinical use of stem cells in equine medicine. Can Vet J 2008 Oct;49(10):1009-17.
    pubmed: 19119371
19. Del Bue M, Riccò S, Ramoni R, Conti V, Gnudi G, Grolli S. Equine adipose-tissue derived mesenchymal stem cells and platelet concentrates: their association in vitro and in vivo. Vet Res Commun 2008 Sep;32 Suppl 1:S51-5.
    doi: 10.1007/s11259-008-9093-3pubmed: 18683070google scholar: lookup
20. Giraldo A, Koch TG, Madan P, Lepage S, Monteith G, Alizadeh AH, Tran A, Mortagy N, Koenig JB. Effect of extracorporeal shockwave therapy on the immunomodulatory and anti-inflammatory properties of cultured equine umbilical cord blood mesenchymal stromal cells. Can J Vet Res 2024 Jul;88(3):87-93.
    pubmed: 38988333